| Browse All

EDAP TMS S.A. (EDAP)

Healthcare | Medical Distribution | Vaulx-En-Velin, France | NasdaqGM
3.49 USD -0.10 (-2.786%) ⇩ (April 17, 2026, 4 p.m. EDT)

Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 12:46 a.m. EDT

EDAP presents a textbook 'value trap' with deteriorating fundamentals (negative 19% revenue growth, negative operating margins, and negative free cash flow). While the short-term technicals show a slight bounce, the long-term future is bleak without a fundamental turnaround that is not currently priced in. The massive concentration of Put OI on extended-dated options signals institutional fear that the stock is heading to par or liquidation levels within the year. Avoid this stock for long-term capital preservation. Selling short-term puts at current low IV could be a tactical play for bearish sentiment, but holding the stock itself is a loser's game.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.085980
AutoARIMA0.087386
AutoETS0.097372
MSTL0.098838

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 70%
H-stat 1.34
Ljung-Box p 0.000
Jarque-Bera p 0.360
Excess Kurtosis -1.04
Attribute Value
Sector Healthcare
Debt to Equity Ratio 142.925
Revenue per Share 1.884
Market Cap 130,812,128
Forward P/E -6.23
Beta -0.08
Profit Margins -41.47%
Website https://focalone.com

As of April 19, 2026, 12:46 a.m. EDT: Options activity shows a distinct divergence in sentiment based on time horizon. Near-term (-1 month, exp 2026-05-15), Call OI is slightly higher than Put OI (285 vs 384 total OI across all strikes, with significant bullish positioning at 7.5 strikes). However, looking further out (3-months+ and Dec 2026 expirations), there is a massive imbalance favoring Puts. In the Dec 2026 expiration, Put OI is roughly 1,500 contracts compared to 1,000 Call OI (330+74+515). The longest-dated (Jan 2027) shows Put OI (330+280=610) significantly outweighing Call OI (626). The 6-month 2026-08-21 strike shows bullish concentration at 7.5 for calls. Overall, the data suggests a short-term speculative momentum play or stop-run anticipation against a backdrop of strong long-term hedging by market makers or major investors who expect a continued decline or significant gap down over the next 6-12 months, contradicting the low IV environment for deep OTM calls in the coming months.


Info Dump

Attribute Value
52 Week Change 1.4236112
Address1 Parc dActivites la Poudrette-Lamartine
Address2 4/6, rue du DauphinE
All Time High 21.64
All Time Low 0.5
Ask 3.4
Ask Size 1
Average Analyst Rating 2.3 - Buy
Average Daily Volume10 Day 28,390
Average Daily Volume3 Month 56,978
Average Volume 56,978
Average Volume10Days 28,390
Beta -0.081
Bid 3.3
Bid Size 1
Book Value 0.518
City Vaulx-En-Velin
Compensation As Of Epoch Date 1,767,139,200
Country France
Crypto Tradeable 0
Currency USD
Current Price 3.49
Current Ratio 1.539
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 3.51
Day Low 3.4
Debt To Equity 142.925
Display Name EDAP TMS
Earnings Call Timestamp End 1,778,184,000
Earnings Call Timestamp Start 1,778,184,000
Earnings Timestamp 1,778,157,000
Earnings Timestamp End 1,778,157,000
Earnings Timestamp Start 1,778,157,000
Ebitda -21,288,000
Ebitda Margins -0.30184
Enterprise To Ebitda -6.488
Enterprise To Revenue 1.958
Enterprise Value 138,106,128
Eps Current Year -0.785
Eps Forward -0.56
Eps Trailing Twelve Months -0.78
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 4.0346
Fifty Day Average Change -0.5445998
Fifty Day Average Change Percent -0.13498235
Fifty Two Week Change Percent 142.36111
Fifty Two Week High 5.05
Fifty Two Week High Change -1.5600002
Fifty Two Week High Change Percent -0.3089109
Fifty Two Week Low 1.21
Fifty Two Week Low Change 2.28
Fifty Two Week Low Change Percent 1.8842975
Fifty Two Week Range 1.21 - 5.05
Financial Currency USD
First Trade Date Milliseconds 870,442,200,000
Float Shares 28,530,913
Forward Eps -0.56
Forward P E -6.232143
Free Cashflow -12,130,500
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.42538
Gross Profits 30,001,000
Has Pre Post Market Data 1
Held Percent Insiders 0.09847
Held Percent Institutions 0.38985002
Implied Shares Outstanding 37,481,986
Industry Medical Distribution
Industry Disp Medical Distribution
Industry Key medical-distribution
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents. The company serves academic, public, and private hospitals as well as urology clinics. EDAP TMS S.A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.
Long Name EDAP TMS S.A.
Market us_market
Market Cap 130,812,128
Market State PRE
Max Age 86,400
Message Board Id finmb_27892
Most Recent Quarter 1,767,139,200
Net Income To Common -29,246,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 129,687,671
Number Of Analyst Opinions 3
Open 3.4
Operating Cashflow -16,409,000
Operating Margins -0.26174
Payout Ratio 0.0
Phone 33 4 72 15 31 50
Previous Close 3.59
Price Eps Current Year -4.44586
Price Hint 4
Price To Book 6.7374516
Price To Sales Trailing12 Months 1.8547808
Profit Margins -0.41467997
Quick Ratio 1.159
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.33333
Region US
Regular Market Change -0.0999999
Regular Market Change Percent -2.78551
Regular Market Day High 3.51
Regular Market Day Low 3.4
Regular Market Day Range 3.4 - 3.51
Regular Market Open 3.4
Regular Market Previous Close 3.59
Regular Market Price 3.49
Regular Market Time 1,776,456,001
Regular Market Volume 50,210
Return On Assets -0.1833
Return On Equity -0.94497
Revenue Growth -0.19
Revenue Per Share 1.884
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 37,481,986
Shares Percent Shares Out 0.0015
Shares Short 56,032
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 58,380
Short Name EDAP TMS S.A.
Short Percent Of Float 0.0034999999
Short Ratio 1.38
Source Interval 15
Symbol EDAP
Target High Price 10.0
Target Low Price 2.5
Target Mean Price 5.5
Target Median Price 4.0
Total Cash 20,452,000
Total Cash Per Share 0.546
Total Debt 27,746,000
Total Revenue 70,527,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.78
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.80185
Two Hundred Day Average Change 0.6881499
Two Hundred Day Average Change Percent 0.24560554
Type Disp Equity
Volume 50,210
Website https://focalone.com
Zip 69,120